News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
193,324 Results
Type
Article (9247)
Company Profile (46)
Press Release (184023)
Multimedia
Podcasts (12)
Webinars (6)
Section
Business (57537)
Career Advice (400)
Deals (7307)
Drug Delivery (24)
Drug Development (21871)
Employer Resources (48)
FDA (3574)
Job Trends (4460)
News (89955)
Policy (6126)
Tag
Academia (1011)
Accelerated approval (6)
Adcomms (4)
Allergies (43)
Alliances (16288)
ALS (65)
Alzheimer's disease (678)
Antibody-drug conjugate (ADC) (89)
Approvals (3659)
Artificial intelligence (256)
Autoimmune disease (42)
Automation (19)
Bankruptcy (38)
Best Places to Work (3922)
BIOSECURE Act (1)
Biosimilars (45)
Biotechnology (27)
Bladder cancer (43)
Brain cancer (17)
Breast cancer (213)
Cancer (1501)
Cardiovascular disease (185)
Career advice (351)
Career pathing (12)
CAR-T (80)
CDC (10)
Cell therapy (216)
Cervical cancer (7)
Clinical research (18128)
Collaboration (656)
Compensation (90)
Complete response letters (7)
COVID-19 (806)
CRISPR (47)
C-suite (332)
Cystic fibrosis (51)
Data (2306)
Denatured (5)
Depression (44)
Diabetes (161)
Diagnostics (2360)
Digital health (14)
Diversity (3)
Diversity, equity & inclusion (12)
Drug discovery (110)
Drug pricing (18)
Drug shortages (3)
Duchenne muscular dystrophy (76)
Earnings (18760)
Editorial (13)
Employer branding (7)
Employer resources (44)
Events (30329)
Executive appointments (369)
FDA (4461)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (1)
Frontotemporal dementia (10)
Funding (529)
Gene editing (82)
Generative AI (21)
Gene therapy (199)
GLP-1 (262)
Government (1044)
Grass and pollen (1)
Guidances (118)
Healthcare (5078)
HIV (27)
Huntington's disease (10)
IgA nephropathy (23)
Immunology and inflammation (53)
Immuno-oncology (14)
Indications (30)
Infectious disease (882)
Inflammatory bowel disease (68)
Inflation Reduction Act (1)
Influenza (32)
Intellectual property (57)
Interviews (59)
IPO (2936)
IRA (7)
Job creations (729)
Job search strategy (299)
JPM (15)
Kidney cancer (2)
Labor market (15)
Layoffs (100)
Leadership (7)
Legal (1032)
Liver cancer (21)
Longevity (6)
Lung cancer (189)
Lymphoma (96)
Machine learning (26)
Management (17)
Manufacturing (211)
MASH (56)
Medical device (3281)
Medtech (3296)
Mergers & acquisitions (4654)
Metabolic disorders (390)
Multiple sclerosis (52)
NASH (5)
Neurodegenerative disease (118)
Neuropsychiatric disorders (27)
Neuroscience (1105)
Neurotech (1)
NextGen: Class of 2026 (1866)
Non-profit (1520)
Now hiring (14)
Obesity (169)
Opinion (81)
Ovarian cancer (39)
Pain (55)
Pancreatic cancer (60)
Parkinson's disease (110)
Partnered (11)
Patents (97)
Patient recruitment (128)
Peanut (14)
People (21157)
Pharmaceutical (8)
Pharmacy benefit managers (2)
Phase 1 (5393)
Phase 2 (7649)
Phase 3 (6380)
Pipeline (1650)
Policy (62)
Postmarket research (675)
Preclinical (3515)
Press Release (34)
Prostate cancer (76)
Psychedelics (17)
Radiopharmaceuticals (63)
Rare diseases (254)
Real estate (1478)
Recruiting (20)
Regulatory (5201)
Reports (10)
Research institute (1163)
Resumes & cover letters (74)
Rett syndrome (8)
RNA editing (5)
RSV (13)
Schizophrenia (38)
Series A (114)
Series B (40)
Sickle cell disease (42)
Special edition (1)
Spinal muscular atrophy (70)
Sponsored (21)
Startups (1377)
State (1)
Stomach cancer (3)
Supply chain (19)
Tariffs (7)
The Weekly (7)
Vaccines (242)
Venture capital (24)
Weight loss (77)
Women's health (31)
Worklife (2)
Date
Last 7 days (173)
Last 30 days (646)
Last 365 days (9021)
2026 (846)
2025 (9033)
2024 (10227)
2023 (11908)
2022 (15879)
2021 (17105)
2020 (15901)
2019 (13845)
2018 (10439)
2017 (9879)
2016 (9578)
2015 (10358)
2014 (7616)
2013 (6141)
2012 (6647)
2011 (7008)
2010 (5893)
Location
Africa (220)
Alabama (23)
Alaska (4)
Arizona (58)
Arkansas (2)
Asia (10058)
Australia (1613)
California (3128)
Canada (939)
China (289)
Colorado (140)
Connecticut (133)
Delaware (95)
Europe (28284)
Florida (393)
Georgia (90)
Hawaii (1)
Idaho (13)
Illinois (213)
India (15)
Indiana (108)
Iowa (5)
Japan (126)
Kansas (24)
Kentucky (7)
Louisiana (11)
Maine (75)
Maryland (383)
Massachusetts (2604)
Michigan (120)
Minnesota (122)
Mississippi (4)
Missouri (46)
Montana (5)
Nebraska (9)
Nevada (28)
New Hampshire (25)
New Jersey (791)
New Mexico (24)
New York (1022)
North Carolina (406)
North Dakota (3)
Northern California (1538)
Ohio (120)
Oklahoma (10)
Oregon (27)
Pennsylvania (622)
Puerto Rico (4)
Rhode Island (18)
South America (257)
South Carolina (11)
Southern California (1211)
Tennessee (45)
Texas (527)
United States (11648)
Utah (142)
Vermont (1)
Virginia (70)
Washington D.C. (22)
Washington State (288)
West Virginia (1)
Wisconsin (44)
193,324 Results for "openeye scientific software".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Cadence Completes Acquisition of OpenEye Scientific
Cadence Design Systems, Inc. (Nasdaq: CDNS) announced today that it has completed the acquisition of OpenEye Scientific Software, Inc. (“OpenEye”).
September 1, 2022
·
4 min read
Press Releases
Eurobio Scientific: 2025 FY revenue
January 28, 2026
·
4 min read
Press Releases
TetraScience Announces Collaboration with Thermo Fisher Scientific to Accelerate Scientific Data and AI Enablement Across the Laboratory
January 13, 2026
·
3 min read
Press Releases
TempraMed Appoints Leading Diabetes Researcher Professor Dr. Lutz Heinemann to its Scientific Advisory Board
A renowned expert in insulin pharmacology, diabetes technology, and temperature-sensitive medication stability joins TempraMed to strengthen scientific leadership
December 10, 2025
·
6 min read
Optibrium Adopts Cheminformatics Toolkits From OpenEye Scientific
Optibrium™ and OpenEye Scientific (OpenEye), leading providers of software and services for drug discovery, today announced that StarDrop™, Optibrium’s software for small molecule design, optimisation and data analysis, is now powered by OpenEye Scientific’s cheminformatics toolkits.
July 22, 2021
·
3 min read
Press Releases
Agilent Announces 21 CFR Part 11 Compliance Software for xCELLigence RTCA eSight
December 2, 2025
·
2 min read
Press Releases
OneMedNet Real-World Data Supports FDA 510(k) Clearance of AI-Powered Scaida BrainCT-ICH Software
January 23, 2026
·
5 min read
Business
OpenEye Scientific Introduces Its Scientific Advisory Board
OpenEye Scientific, an industry leader in computational molecular design, has officially introduced its Scientific Advisory Board, which includes experts in the fields of biophysics and molecular modeling.
October 28, 2021
·
3 min read
Press Releases
Boston Scientific announces agreement to acquire Penumbra, Inc.
January 16, 2026
·
15 min read
Press Releases
AI unlocks unparalleled efficiency gains in Flare™ V11, Cresset’s leading software solution for digital molecular discovery
January 13, 2026
·
1 min read
1 of 19,333
Next
